KOSDAQ · Healthcare · ₩3T
₩85,200-2.74%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 11.1% · as of 26.09.11
Among 36 신약 개발 peers
Quarterly Revenue Growth
“대형 계약의 가치는 후속 개발 진전에 달려 있어요.”
In the company's words · 2026 2분기 filing